Zanamivir for inhal
Ended Awarded
- Contract number
- SPE2DP22F7827
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $23,625
Award facts
- Contract value 100% obligated
- $23,625.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order for $23,625 against the Defense Logistics Agency Troop Support Medical's prime vendor pharmaceutical contract is for 8509429740 units of Zanamivir for inhalation to Glaxosmithkline, LLC. The contract has no set-aside designation and requires delivery by April 17, 2023. Glaxosmithkline will provide the inhaled antiviral drug, used to treat influenza, to support the Defense Logistics Agency's medical supply chain programs. The firm fixed price order was awarded on September 27, 2022 for delivery to a location in Research Triangle Park, North Carolina.
Quick answers
Who was awarded contract SPE2DP22F7827?
SPE2DP22F7827 was awarded to Glaxosmithkline, LLC by Medical Supply Chain (Troop Support) on September 27, 2022.
How much is contract SPE2DP22F7827 worth?
The government has obligated $23,625 on SPE2DP22F7827.
Is contract SPE2DP22F7827 an order under another contract?
Yes. SPE2DP22F7827 is a delivery order under SPE2DP22D0009, an indefinite delivery contract.
Was contract SPE2DP22F7827 competed?
The extent of competition for SPE2DP22F7827 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award